Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Filament Health Corp N.FH

Alternate Symbol(s):  FLHLF

Filament Health Corp. is a Canada-based clinical-stage natural psychedelic drug development company. The Company’s platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The Company’s first three botanical drug candidates are standardized, purified extracts of psilocybe cubensis fruiting bodies include: PEX010 Psilocybin ... see more

Bullboard (NEO:FH)

View:
Post by fossil8on Jan 02, 2024 6:48pm

Deal

I am one happy camper that this deal did not go through.  It was bad from the get go. What has not been reported is what the cost was to walk away and WHY was it terminated. Filament is bleeding ...more  
Post by lscfaon Sep 27, 2023 11:19am

Jupiter redemptions

Jupiter had $160 million cash at March 31, 2023 and $15 million at June 30, 2023
Comment by lscfaon Aug 15, 2023 11:23am

RE:1-for-10 rollback

Jupiter has $217 mil Cdn cash & securities but assuming 90% redemptions and $13.3 mil transaction costs so only $7 mil cdn cash after RTO and total of 29.3 mil shs o/s
Post by lscfaon Aug 15, 2023 11:01am

1-for-10 rollback

Filament shareholders only get 20,600,000 shares in merged co. This is 1/10 of FH shares o/s.      https://www.sec.gov/Archives/edgar/data/1988363/000121390023067070/ff42023 ...more  
Post by fossil8on Aug 08, 2023 7:27pm

Patience Required

This stock is going to rock especially with the new alliance. Doors will open now and funds will be available.  Got a dream team running it.  We will all have to be patient  but it is a ...more  
Post by Betteryear2on Jun 30, 2023 8:09am

FILAMENT HEALTH ENTERS EXCLUSIVE LICENSING AGREEMENT

NeoLumina's license for Filament's botanical psilocybin drug candidate provides exclusive global right to clinical and commercial development for eating disorders VANCOUVER, BC, June 30 ...more  
Post by Firepokeron Apr 26, 2023 8:09am

2023 Spring Event and Media Appearances

https://www.filament.health/news/filament-health-announces-spring-2023-event-and-media-appearances
Post by Firepokeron Apr 26, 2023 8:04am

Filament TV interview on CTV today...excellent exposure for

CTV your morning at 8:10am eastern 5:10 pacific MEDIA -On Wednesday, April 26, at 8:10 a.m. ET, Mr. Lightburn will appear on CTV’s Your Morning to discuss the Company’s recent development of GMP MDMA ...more  
Post by Firepokeron Apr 22, 2023 6:55am

Great Partnership

https://mugglehead.com/pharmala-biotech-and-filament-health-partner-to-release-mdma-capsules/
Post by CmMuskieon Aug 18, 2022 5:03pm

Eight paten issued!

https://www.newswire.ca/news-releases/filament-health-announces-eighth-patent-issuance-888386340.html
Post by CmMuskieon Aug 16, 2022 3:41pm

Worth noting. Insiders own about 70% of the shares.

Insider Transactions Reported - Last Two Years Insider Transaction Type Value Date Shares LIGHTBURN (BENJAMIN ...more  
Comment by younginvestor27on Apr 16, 2022 5:17pm

RE:Hi

is it me your looking for
Post by SHeditorialon Apr 13, 2022 11:52am

Safe, Natural Psychedelics play worth watching

https://stockhouse.com/opinion/interviews/2022/04/12/unlocking-healing-potential-safe-natural-psychedelics
Post by Betteryear2on Jan 31, 2022 3:53pm

APPROVAL FOR PHASE II CLINICAL TRIAL FOR DEPRESSION

Trial to investigate the effects of Filament's botanical psilocybin drug candidate and Cybin Therapeutics' protocols in treating major depressive disorder in patients taking SSRIs. Patient ...more  
Post by Betteryear2on Nov 03, 2021 2:58pm

The Power Play by The Market Herald Releases New Interviews

Filament Health has received FDA authorization to initiate the first clinical trial using naturally sourced psychedelic substances. The phase 1 trial will include 20 healthy subjects and examine the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities